Lunit Inc.
328130
Rang in aandelen
#11596
Lunit Inc., established in 2013 and headquartered in Seoul, South Korea,... Lunit Inc., established in 2013 and headquartered in Seoul, South Korea, develops and supplies advanced artificial intelligence software solutions aimed at improving cancer screening, diagnosis, and treatment. The company's portfolio includes AI-powered tools for analyzing medical images like chest X-rays and mammograms, as well as intelligent biomarkers for immune phenotyping and precise PD-L1 quantification, which are vital for optimizing immunotherapy.
Aandeelprijs
$8.52
Marktkapitalisatie
$633.87M
Verandering (1 dag)
6.79%
Verandering (1 jaar)
1,018.96%
Land
KR
Handel Lunit Inc. (328130)
Categorie
Healthcare
Koersgeschiedenis voor Lunit Inc. (328130)
Hoogste slotkoers: $0.77 op 2024-05-01
Laagste slotkoers: $0.36 op 2016-04-01
Laagste slotkoers: $0.36 op 2016-04-01
Koersgeschiedenis van Lunit Inc. van 2016 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2024 | 21.01% |
| 2023 | 63.98% |
| 2022 | -48.35% |
| 2021 | -27.48% |
| 2020 | -16.42% |
| 2019 | 54.09% |
| 2018 | 66.29% |
| 2017 | 3.05% |
| 2016 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $68.99 | -9.39% |
US
|
|
| $136.63 | -25.98% |
AU
|
|
| $62.83 | 90.74% |
US
|
|
| $67.71 | -20.60% |
US
|
|
| $76.26 | 521.98% |
US
|
